NYR In Vivo Trial Results Show Further Positive Results
Last Friday, Nyrada released further positive results from an animal trial using a mouse model genetically modified to mimic human-like characteristics concerning cholesterol metabolism and [...]
ReNerve Shareholder Newsletter August 2021
Some notable highlights : Presentation of ReNerve at the Royal Australian College of Surgeons Annual Scientific Meeting in Melbourne Launch of the company’s new website renerve.com.au Successful [...]
Incannex submits HREC proposal and FDA pre-IND meeting request for Psi-GAD psilocybin therapy for Generalised Anxiety Disorder
We wish to draw your attention to an announcement and presentation released by Incannex (ASX:IHL) this week. The company has completed a Human Research Ethics Committee (HREC) submission for a [...]